Keyphrases
Israel
100%
Bloodstream Infection
98%
Carbapenem-resistant Acinetobacter Baumannii
56%
Neonatal Intensive Care Unit
56%
Escherichia Coli
54%
Bacteremia
47%
Risk Factors
42%
Hospital Admission
41%
Carbapenem-resistant Enterobacteriaceae
40%
Antimicrobial Resistance
39%
Carbapenem Resistance
35%
Hospital-onset
34%
Peripheral Blood
32%
Acinetobacter Baumannii (A. baumannii)
32%
Pseudomonas Aeruginosa (P. aeruginosa)
31%
Erythrocytes
29%
Fecal Carriage
29%
Hospitalized Patients
28%
Extended-spectrum-lactamase
28%
Vancomycin-resistant Enterococci
28%
KPC-2
28%
National Cohort Study
28%
Clostridium Difficile Infection
27%
Dextran Sulfate Sodium
27%
Red Blood Cell Aggregation
27%
Clinical Characteristics
27%
Tel Aviv
25%
Sentinel
25%
Producing Escherichia Coli
24%
Klebsiella Pneumoniae (K. pneumoniae)
22%
Israeli
21%
Enterobacteriaceae
21%
Odds Ratio
21%
1-year Mortality
21%
Lipoproteins
20%
Fibrinogen
20%
Colistin
20%
Multidrug-resistant
20%
LDL Apheresis
19%
Cholesterol
19%
Fourier Transform Infrared Spectroscopy (FT-IR)
19%
Plasmid
18%
Comorbidity
17%
Infection Rate
17%
Medical Ward
17%
Triglycerides
16%
Antibiotic Use
16%
β-lactamase Inhibitor
16%
Lactams
16%
Carbapenemase-producing Enterobacterales
16%
Medicine and Dentistry
Bloodstream Infection
57%
Infection
52%
Carbapenem
48%
Escherichia coli
43%
Acinetobacter Baumannii
43%
Carbapenem-Resistant Enterobacteriaceae
40%
Neonatal Intensive Care Unit
40%
Antibiotic Resistance
36%
Penicillinase
31%
Antibiotics
29%
Enterococcus faecium
29%
Vancomycin Resistant Enterococcus
28%
Infection Control
28%
Intensive Care Unit
26%
Pathogen
25%
Bacteremia
21%
Extended Spectrum Beta Lactamase
18%
Polymerase Chain Reaction
18%
Intensive Care
17%
Wound
16%
Drug Therapy
16%
Hysterectomy
16%
Enterobacteriaceae
16%
Cohort Effect
16%
Newborn Intensive Care
16%
Cohort Analysis
15%
Carbapenemase
14%
Risk Perception
13%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
13%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
13%
Atherosclerosis
13%
Laboratory Diagnosis
13%
Effusion
13%
Clostridium Difficile Infection
13%
Meningitis
13%
Leg
13%
LDL Apheresis
13%
Heat Tolerance
13%
Genome Sequencing
13%
Ribosome DNA
13%
Peripheral Vascular Disease
13%
Thorax Radiography
13%
Congenital Tuberculosis
13%
Wound Infection
13%
Peptoclostridium difficile
13%
DNA Sequence
13%
Endoscope
13%
Patient Isolation
13%
COVID-19
13%
Adenosine Triphosphate
13%
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
85%
Infection
53%
Escherichia coli
50%
Bacteremia
46%
Acinetobacter Baumannii
45%
Antibiotics
37%
Antimicrobial Resistance
36%
Carbapenem
34%
Pseudomonas aeruginosa
33%
Penicillinase
30%
Extended Spectrum Beta Lactamase
27%
Enterobacteriaceae
18%
Antimicrobial Therapy
17%
Disease
17%
Adverse Outcome
16%
Lactam
16%
Klebsiella
15%
Cohort Study
15%
Hypercholesterolemia
15%
Syndrome
15%
Diclofenac
13%
Low Density Lipoprotein
13%
Clostridium Difficile Infection
13%
Lipoprotein
13%
Atherosclerosis
13%
Diarrhea
13%
Quinolone Derivative
13%
Rhabdomyolysis
13%
Peptoclostridium difficile
13%
Fibrinogen
13%
Fourier Transform Infrared Spectroscopy
13%
Wound Infection
13%
Tuberculosis
13%
Cerivastatin
13%
Dextran Sulfate
13%
Homocysteine
13%
Coronavirinae
13%
Enterobacter
13%
Microorganism
13%
Bacterial Infection
13%
2009 H1N1 Influenza
13%
Gram Negative Sepsis
13%
Lung Tuberculosis
13%
Epidemiology
13%
Carbapenemase
13%
Antibiotic Agent
11%
Comorbidity
10%
Antibiotic Resistance
10%
Infectious Agent
9%
Acinetobacter Infection
9%
